Becton, Dickinson and Company is one of the world's largest global medical technology companies, developing technologies, services and solutions across medical discovery, diagnostics and the delivery of care. The company operates in nearly every country, employs approximately 75,000 associates and has been in operation for more than 125 years. Its technical work spans medical technology, diagnostics, life sciences, interventional technologies, automated diagnostic systems, safety-engineered devices, clinical operations optimization and patient safety technology.
The business is organised into three specialised segments: Medical, Life Sciences and Interventional, each addressing distinct challenges in healthcare. Technical output includes the first safety-engineered syringe, an industry first in patient and healthcare worker safety, and pioneering automated diagnostic systems intended to improve diagnostics and clinical operations. Billions of products are delivered annually.
Research and development investment exceeds $1 billion a year. The company describes its purpose as "advancing the world of health" and characterises its workforce as associates, with a stated orientation toward long-standing partnership with frontline healthcare providers, improving patient safety and expanding access to healthcare. Further information is available at https://bd.com/.
